IP Library Granted Patent US 9,205,000
Granted Patent B2
US 9,205,000 · App. 13/931,353 · Granted Dec 8, 2015

Reduced-pressure treatment systems and methods employing debridement mechanisms

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,205,000
App. No.
13/931,353
Granted
Dec 8, 2015
Kind
B2
Abstract

Reduced-pressure treatment systems and methods are disclosed that employ debridement mechanisms to remove unwanted tissue. In one instance, a reduced-pressure treatment system for treating a tissue site on a patient includes a manifold member for distributing reduced pressure to the tissue site, a support member for disposing proximate the tissue site and the manifold, and a debridement mechanism coupled to the support member. The debridement mechanism is for debriding the tissue site. The system further includes a sealing drape for placing over the tissue site and manifold member. The sealing drape is operable to form a fluid seal over the tissue site and manifold member. The system also includes a reduced-pressure subsystem for delivering a reduced pressure to the sealing drape. The system may further include a chemical-debridement subsystem. Other systems, manifolds, and methods, are disclosed.

Claims (29)

1. A manifold member for debriding a tissue site on a patient, the manifold member comprising:

a manifold material formed from a porous material that contracts in response to reduced pressure;

a support member coupled to the manifold material; and

a pincer including a first blade and a second blade, each blade having a proximal end coupled to the support member and a distal end for positioning at the tissue site, the distal ends of the first and second blades being movable for debriding the tissue site in response to the manifold material when contracting;

wherein the distal ends of the first blade and the second blade move between an open position and a closed position under the influence of the reduced pressure.

2. The manifold member of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site.

3. The manifold member of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the chemical-debridement subsystem comprises a debriding chemical reservoir in fluid communication with the sealing drape whereby the debriding chemical is delivered to the tissue site.

4. The manifold member of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae.

5. The manifold member of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata.

6. The manifold member of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae.

7. The manifold member of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata.

8. The manifold member of claim 1 , further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is a chemical selected from the group consisting of: collagenase, ficin, pepsin, trypsin, chymotrypsin, papain and elastase.

9. A method for debriding a tissue site on a patient, the method comprising:

placing a manifold member formed from a porous material that contracts response to reduce pressure proximate the tissue site, wherein the manifold member comprises a support member and a pincer including a first blade and a second blade, each blade having a proximal end coupled to the support member and a distal end for positioning at the tissue site, the distal ends being movable for debriding the tissue site in response to the manifold member when contracting;

disposing a sealing drape over the manifold member and the patient's epidermis;

forming a fluid seal between the sealing drape and the patient's epidermis to form a fluid seal over the tissue site for application of reduced pressure to the manifold member; and

providing a reduced pressure to the manifold member whereby the distal ends of the first blade and the second blade move between an open position and a closed position under the influence of the reduced pressure.

10. The method of claim 9 , further comprising introducing a debriding chemical to the tissue site.

11. The method of claim 9 , further comprising introducing a debriding chemical to the tissue site and wherein the debriding chemical is one or more enzymes isolated from insect larvae.

12. The method of claim 9 , further comprising introducing a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata.

13. The method of claim 9 , further comprising introducing a debriding chemical to the tissue site, and wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae.

14. The method of claim 9 , further comprising introducing a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata.

15. The method of claim 9 , further comprising introducing a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae, and wherein the debriding chemical is a chemical selected from the group consisting of: collagenase, ficin, pepsin, trypsin, chymotrypsin, papain and elastase.

16. The method of claim 9 , further comprising introducing a debriding chemical to the tissue site, and flushing the tissue site.

17. A method of manufacturing a manifold member for treating a tissue site on a patient, the method comprising:

forming a manifold member for placing over a tissue site, the manifold member having a support member;

coupling a debridement mechanism to the support member; and

wherein the debridement mechanism is configured to debride a tissue site under the influence of reduced pressure.

18. The method of claim 17 , wherein the debridement mechanism comprises a debridement implement.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066445/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0218 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2014
From: SEEGERT, CHARLES ALAN
To: KCI LICENSING, INC.
Reel/Frame 032649/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2014
From: WILKES, ROBERT P.
To: KCI LICENSING, INC.
Reel/Frame 032597/0190 →